Lv4
450 积分 2026-01-13 加入
322P Human epidermal growth factor receptor 2 (HER2)-directed therapies administered after trastuzumab deruxtecan (T-DXd) remain effective in patients (pts) with metastatic breast cancer (mBC): Exploratory analysis from DESTINY-Breast02 and -03
7小时前
求助中
Mechanisms of resistance to antibody-drug conjugates in breast cancer
1天前
已完结
Sequencing antibody–drug conjugates in metastatic breast cancer: A systematic review
3天前
已完结
Oral Chemotherapy in Elderly Women with Metastatic Breast Cancer
22天前
已完结
Perioperative Management of Antithrombotic Therapy
26天前
已完结
Application of thrombopoietic agents in cancer therapy-induced thrombocytopenia: A comprehensive review
29天前
已完结
Avatrombopag for chemotherapy-induced thrombocytopenia in patients with non-haematological malignancies: an international, randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Optimal management of chemotherapy-induced thrombocytopenia with thrombopoietin receptor agonists
1个月前
已完结
Thrombopoietin receptor agonist in chemotherapy-induced thrombocytopenia
1个月前
已完结
Thrombopoietin-Receptor Agonists in Chemotherapy-Induced Thrombocytopenia
1个月前
已完结
皖公网安备34019202002308
